Results 161 to 170 of about 3,235 (226)

Clinical Benefits of Tezepelumab in a Real-World Cohort of Patients With Severe Uncontrolled Asthma in Castilla-La Mancha, Spain. [PDF]

open access: yesOpen Respir Arch
Bujalance-Cabrera C   +8 more
europepmc   +1 more source

Remission of Eosinophilic Otitis Media With Tezepelumab

open access: yesJournal of Investigational Allergology and Clinical Immunology
Diana Betancor   +6 more
openaire   +1 more source

Targeting the Epithelial Alarmin Pathway with Tezepelumab in Highly Comorbid, Biologic-Experienced Severe Asthma: 52-Week Real-World Outcomes. [PDF]

open access: yesJ Clin Med
González-Pérez R   +5 more
europepmc   +1 more source

Effects of Tezepelumab in "United Airway Disease" (Asthma and CRSwNP). [PDF]

open access: yesCase Rep Pulmonol
Lupia C   +9 more
europepmc   +1 more source

Delphi Consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP) on the management of severe asthma in children and adolescents. [PDF]

open access: yesMultidiscip Respir Med
Miraglia Del Giudice M   +6 more
europepmc   +1 more source

Emerging targeted therapies for chronic obstructive pulmonary disease: from symptom control to precision medicine. [PDF]

open access: yesFront Pharmacol
Chen G   +11 more
europepmc   +1 more source

Prevalence of dysphagia and eosinophilic esophagitis in patients with inflammatory bowel disease or type 2 inflammation: a cross-sectional multicenter screening study. [PDF]

open access: yesTher Adv Gastroenterol
Bäuerle M   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy